IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle -mediated vessel formation by targeting the [beta]-catenin pathway
The proangiogenic cytokine Interleukin-3 (IL-3) is released by inflammatory cells in breast and ovarian cancer tissue microenvironments and also acts as an autocrine factor for human breast and kidney tumor-derived endothelial cells (TECs). We have previously shown that IL-3-treated endothelial cell...
Gespeichert in:
Veröffentlicht in: | Oncogene 2018-03, Vol.37 (13), p.1175 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!